Jag Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-5,315
Closed -$2.31M 157
2023
Q3
$2.31M Sell
5,315
-70
-1% -$31.8K 0.28% 62
2023
Q2
$2.39M Sell
5,385
-29
-0.5% -$13.4K 0.28% 66
2023
Q1
$2.49M Sell
5,414
-203
-4% -$96.6K 0.32% 64
2022
Q4
$2.88M Buy
5,617
+646
+13% +$328K 0.42% 53
2022
Q3
$2.26M Buy
4,971
+681
+16% +$326K 0.32% 62
2022
Q2
$2.07M Sell
4,290
-32,653
-88% -$16.2M 0.26% 68
2022
Q1
$13.3M Buy
36,943
+32,563
+743% +$14.9M 1.31% 27
2021
Q4
$2.03M Buy
4,380
+119
+3% +$50.1K 0.16% 82
2021
Q3
$1.59M Sell
4,261
-146
-3% -$55.5K 0.12% 93
2021
Q2
$1.68M Sell
4,407
-37,651
-90% -$14.4M 0.13% 90
2021
Q1
$15.1M Buy
42,058
+7,829
+23% +$2.52M 1.33% 27
2020
Q4
$11M Buy
34,229
+31,076
+986% +$9.54M 0.99% 29
2020
Q3
$847K Buy
3,153
+1
+0% +$269 0.09% 103
2020
Q2
$829K Sell
3,152
-29
-0.9% -$7.74K 0.1% 96
2020
Q1
$722K Sell
3,181
-750
-19% -$204K 0.11% 96
2019
Q4
$1.19M Buy
3,931
+269
+7% +$74K 0.13% 115
2019
Q3
$879K Hold
3,662
0.11% 119
2019
Q2
$1.03M Buy
+3,662
New +$1M 0.12% 113

Other funds holding ELV

Jag Capital Management's ELV Position: Q4 2023 in Review

Jag Capital Management sold out of Elevance Health (ELV) in Q4 2023, closing a stake of 5,315 shares — an estimated $2.31M sold.

Jag Capital Management first reported a position in ELV in Q2 2019 and held it in 18 quarters. The position peaked at $15.1M in Q1 2021. 1,656 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

  • Jag Capital Management reported no remaining Elevance Health position as of Q4 2023 after selling out during the quarter.
  • Jag Capital Management sold 5,315 Elevance Health shares in Q4 2023, an estimated $2.31M.
  • Jag Capital Management first reported a position in Elevance Health in Q2 2019 and held it in 18 quarters.
  • Jag Capital Management's Elevance Health position peaked at $15.1M in Q1 2021.
  • 1,656 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on Jag Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.